Cargando…

Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression

AIMS: Growing evidence suggests that vascular endothelial growth factor (VEGF) may be involved in the neuronal mechanisms underlying both depression aetiology and the response to ketamine treatments. The aim of this study was to examine whether changes in plasma VEGF levels are associated with the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Wei, Zhou, Yan-Ling, Wang, Cheng-Yu, Lan, Xiao-Feng, Zhang, Bin, Zhou, Su-Miao, Yan, Su, Yang, Ming-Zhe, Nie, Sha, Ning, Yu-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132091/ https://www.ncbi.nlm.nih.gov/pubmed/34035893 http://dx.doi.org/10.1177/20451253211014320

Ejemplares similares

Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
por: Zheng, Wei, et al.
Publicado: (2021)

Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation
por: Zheng, Wei, et al.
Publicado: (2020)

Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
por: Zheng, Wei, et al.
Publicado: (2020)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study
por: Huang, Xing-Bing, et al.
Publicado: (2020)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
por: Liu, Haiyan, et al.
Publicado: (2023)

Serum BDNF Levels are Not Associated with the Antidepressant Effects of Nonconvulsive Electrotherapy
por: Zheng, Wei, et al.
Publicado: (2020)

Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
por: Zheng, Wei, et al.
Publicado: (2021)

Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?
por: Thakurta, Rajarshi Guha, et al.
Publicado: (2012)

miR-98-5p plays a critical role in depression and antidepressant effect of ketamine
por: Huang, Chaoli, et al.
Publicado: (2021)

Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
por: Zhou, Yanling, et al.
Publicado: (2021)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure
por: Li, Su-Xia, et al.
Publicado: (2014)

Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
por: Cui, Meiying, et al.
Publicado: (2021)

Association of Neurofilament Light Chain With the Antidepressant Effects of Low-Dose Ketamine Infusion Among Patients With Treatment-Resistant Depression
por: Lin, Wei-Chen, et al.
Publicado: (2023)

Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis
por: Zhou, Yan-Ling, et al.
Publicado: (2020)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

Ketamine: stimulating antidepressant treatment?
por: Malhi, Gin S., et al.
Publicado: (2016)

Immunoregulation and antidepressant effect of ketamine
por: Zhang, Nan, et al.
Publicado: (2021)

Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
por: Zheng, Wei, et al.
Publicado: (2023)

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Nikkheslat, Naghmeh
Publicado: (2021)

Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
por: Zhan, Yanni, et al.
Publicado: (2020)

Plasma Levels of Brain-Derived Neurotrophic Factor and S100B in Relation to Antidepressant Response to Ketamine
por: Jiang, Haitang, et al.
Publicado: (2021)

The Ketamine Antidepressant Story: New Insights
por: Alshammari, Tahani K.
Publicado: (2020)

The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020)

The antidepressant properties of ketamine (literature review)
por: Chamsi, F. Z., et al.
Publicado: (2023)

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
por: Xu, Annie J., et al.
Publicado: (2015)

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
por: Browne, Caroline A., et al.
Publicado: (2013)

Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb
por: Ma, Shuangshuang, et al.
Publicado: (2023)

Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action
por: Aleksandrova, Lily R., et al.
Publicado: (2017)

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
por: Yang, Bangkun, et al.
Publicado: (2016)

Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
por: Duman, Ronald S.
Publicado: (2018)

Ketamine as Antidepressant? Current State and Future Perspectives
por: Hasselmann, H. W.W.
Publicado: (2014)

Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?
por: Chaki, Shigeyuki
Publicado: (2017)

Structural Integrity in the Sustained Antidepressant Effect of Ketamine
por: Belujon, Pauline
Publicado: (2017)

Ketamine: a new chapter in antidepressant development
por: Zarate, Carlos A.
Publicado: (2020)

NMDAR inhibition-independent antidepressant actions of ketamine metabolites
por: Zanos, Panos, et al.
Publicado: (2016)

Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
por: Bowman, Melodi A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d7bcb1tg9j4ebf17a6kqj4f580